Hervé Tilly

8PUBLICATIONS
93CO-AUTHORS
Liquid biopsiesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 02, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly

|Sep 25, 2025
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.

Florence Broussais, Elise Pennings, Natacha Bolanos

|Sep 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.

Franck Morschhauser, Gilles Salles, Laurie H Sehn

|Nov 22, 2023
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial.

Eva Hoster, Marie-Hélène Delfau-Larue, Elizabeth Macintyre

|Jul 28, 2023
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma.

Pier Luigi Zinzani, Jiří Mayer, Christopher R Flowers

|Apr 18, 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.

Guillaume Cartron, Emmanuel Bachy, Hervé Tilly

Pageof 2

Frequent Collaborators

3 joint publications

Franck Morschhauser

3 joint publications

Gilles Salles

3 joint publications

Guillaume Cartron

3 joint publications

Christopher R Flowers